Li Shen

11PUBLICATIONS
122CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 21, 2026
Dual Inhibition of TRIP13 and Aurora A Induces Mitotic DNA Damage and Concurrent Pyroptotic-Apoptotic Cell Death in Rb-Deficient Cancer Cells.

|Feb 09, 2026
Antigen presentation requirements for effective cDC1-based cancer immunotherapy.

Josué E Pineda, Tomoyuki Minowa, Li Shen

|May 13, 2025
Human Papillomavirus Integration Induces Oncogenic Host Gene Fusions in Oropharyngeal Cancers.

Nusrat Khan, Keiko Akagi, Shiming Jiang

|Jan 24, 2025
Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer.

Tanvi H Visal, Recep Bayraktar, Petra den Hollander

|Aug 16, 2024
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities.

C Allison Stewart, Lixia Diao, Yuanxin Xi

|Jun 08, 2023
Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer.

Kavya Ramkumar, Azusa Tanimoto, Carminia M Della Corte

Pageof 2

Frequent Collaborators

10 joint publications

Jing Wang

3 joint publications

Soma Ghosh

3 joint publications

Qi Wang

3 joint publications

Mitchell J Frederick